tradingkey.logo

WGRX

WGRX
查看詳細走勢圖
0.312USD
-0.007-2.10%
收盤 02/06, 16:00美東報價延遲15分鐘
27.89M總市值
虧損本益比TTM

WGRX

0.312
-0.007-2.10%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-2.10%

5天

-13.05%

1月

-22.63%

6月

-58.89%

今年開始到現在

-21.95%

1年

0.00%

查看詳細走勢圖

TradingKey WGRX股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Wellgistics Health Inc當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名148/205位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現非常差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

WGRX評分

相關信息

行業排名
148 / 205
全市場排名
491 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

WGRX亮點

亮點風險
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
業績增長期
公司處於發展階段,最新年度總收入18.13M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入18.13M美元
估值高估
公司最新PE估值-0.25,處於3年歷史高位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉851.12K股

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

WGRX新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

WGRX簡介

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
公司代碼WGRX
公司Wellgistics Health Inc
CEOMr. Brian Norton
網址https://wellgisticshealth.com/
KeyAI